TRAF2 and neoplasm: As a result, loss of mLST8 ubiquitination by either mutating the K305/K313 or depleting the E3 ligase TRAF2 enhances mTORC2 activation and tumor growth, while knockout of the deubiquitinase OTUD7B exhibits opposite phenotypes [62].